Innovation Showcase returns to highlight SickKids technologies and innovators

The SickKids Innovation Showcase is returning for its second year, bringing together the latest in cutting-edge innovation at The Hospital for Sick Children (SickKids) with investors who can help advance ideas with the potential to improve health outcomes for patients. Hosted by the Industry Partnerships & Commercialization office at SickKids, the SickKids Innovation Showcase celebrates some of the most advanced health and life sciences ideas from the labs and clinics of SickKids innovators.

Attendees, primarily made up early-stage investors, venture capitalists, as well as pharmaceutical and biotechnology firms, get unparalleled access to emerging therapeutic and diagnostic technologies with high potential for market disruption and clinical impact.

Last year, over 200 people tuned into the virtual event to learn about the most advanced life science opportunities from SickKids, as well as to hear perspectives from top industry experts. This year, the event features seven of the top opportunities ripe for partnerships.

The virtual Innovation Showcase will be held on Tuesday, May 17. The Innovation Showcase includes pitch presentations from biopharmaceutical and medical technology research leads, followed by question-and-answer sessions and networking opportunities to meet SickKids innovators. Innovators will also have the chance to secure $10,000 in funding for their research, based on the audience’s vote for best presentation of the day.

Interested in attending?

Visit the IP&C website for registration details, and to learn more about how we work with external partners to advance SickKids research.

Register nowExternal Link

Technologies

Check out the innovators and technologies that will be featured at the SickKids Innovation Showcase.

Biopharma

Novel Treatments for Cystic Fibrosis: Moving beyond CFTR modulators

Lisa Strug, Ph. D.

Senior Scientist, Genetics and Genome Biology Associate Director, The Centre for Applied Genomics

Johanna Rommens, PhD

Senior Scientist Emeritus, Genetics and Genome Biology

MedTech

MATCH: Machine Learning-based robust assay to predict cardiotoxicity of pharmaceuticals 

Jason T. Maynes

Chief, Anesthesia and Pain Medicine Curtis Joseph and Harold Groves Chair in Anesthesia and Pain Medicine Associate Chief of Perioperative Services Research Scientist, Molecular Medicine

Yu Sun

Professor, Canada Research Chair in Micro and Nano Engineering Systems, Director, University of Toronto Robotics Institute

AtriumDB: Integrated AI/ML-based platform to store, recapitulate and interrogate waveform data

 

Mjaye Mazwi, MBChB, MD

Co-Chair, Artificial Intelligence Medicine for Kids Staff Physician, Cardiology Project Investigator, Translational Medicine

Robert Greer, B.Eng, M.Sc

Program Manager, Critical Care Medicine Technical Lead, Artificial Intelligence in Medicine (AIM)

Andrew Goodwin, B.Eng, PhD(C)

Research Collaborator, Critical Care Medicine

Panelists

To provide real-world investor perspective, the event features several experts from top life sciences investment firms across North America.

Biopharma

Vyas Ramanan, PhD

Principal, Third Rock Ventures

Ann Schlesinger, PhD

Director, External Science & Partnering at Novartis Institutes for BioMedical Research, Novartis Institutes for Biomedical Research

Vineeta Agarwala, MD, PhD

General Partner, Andreesen Horowitz

Medtech

 

James Hardiman, MBA

Partner, Data Collective (DCVC)

Shobha Parthasarathi, PhD

VP, External Innovation and New Ventures, Xontogeny

Andres Tellez, PhD

Sr. Director, NewCo Development, Johnson & Johnson Innovation - JJDC